In a report released yesterday, Larry Biegelsen from Wells Fargo maintained a Hold rating on Zimmer Biomet Holdings (ZBH – Research Report), with a price target of $113.00. The company’s ...

Zimmer Biomet (ZBH) came out with quarterly earnings of $2.31 per share, beating the Zacks Consensus Estimate of $2.30 per share. This compares to earnings of $2.20 per share a year ago.

Adjusted Tax Rate: 17.5% for the fourth quarter of 2024. Zimmer Biomet Holdings Inc (NYSE:ZBH) reported nearly 5% constant currency sales growth in Q4 2024, marking the 12th consecutive quarter of mid ...

Price is one of the main reasons more motorists aren’t swapping their petrol or diesel car for an electric one, so we’ve put together a list of the cheapest electric cars on sale in 2025.

Zimmer Biomet Holdings Inc is a global leader in medical technology, specializing in designing and manufacturing orthopedic reconstructive products, including knee and hip replacements. Beyond ...

Zimmer Biomet Holdings, Inc. ZBH posted fourth-quarter 2024 adjusted earnings per share (EPS) of $2.31, beating the Zacks Consensus Estimate by a penny. The adjusted figure increased 5% year over ...

Our expert, award-winning staff selects the products we cover and rigorously researches and tests our top picks. If you buy through our links, we may get a commission. Caroline Igo (she/her/hers ...

Despite reporting better-than-expected Q4 2024 results, shares of Zimmer Biomet (NYSE:ZBH) fell in the morning hours Thursday after the orthopedic device maker set its 2025 outlook below consensus.

Zimmer Biomet posted Q4 adjusted EPS of $2.31, surpassing estimates, with sales of $2.02B, driven by strong knee and hip product growth. The company expects FY25 adjusted EPS of $8.15-$8.35 ...

On Thursday, Zimmer Biomet Holdings, Inc (NYSE:ZBH) reported fourth-quarter adjusted EPS of $2.31, up from $2.20 a year ago, beating the Street estimates of $2.30. The orthopedic giant reported ...